NCT01477619View on ClinicalTrials.gov

Effects of Smoking, Age and Body Size on Pharmacokinetics, Safety and Tolerability on Tasimelteon in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Tasimelteon

20mg single dose on Day 1

Trial Locations (1)

Unknown

Bio-Kinetic Clinical Applications, Springfield

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY